ACRS Aclaris Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$4.39
· % 处于52周区间
· 高于低点
· 至高点
$1.7452周低点
$6.6052周高点
市值 (MRQ)
$614M
P/E (TTM)
-7.6
EPS (TTM)
$-0.58
收入 (TTM)
$8M
您的徽章
52周区间
$2–$7
分析师评级
STRONG BUY
目标价
$10
P/E
-7.6
ROE
-59.1%
净利润率
-921.5%
您的徽章条为空 — 在此页面上任意位置固定一个指标。
ACRS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.39
市值 (MRQ)
$614M
P/E (TTM)
-7.6
EPS (TTM)
$-0.58
收入 (TTM)
$8M
ROE (TTM)
-59.1%
52周区间
$2–$7
ACRS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$8M2017-12-31 → 2025-12-31
EPS$-0.532019-12-31 → 2025-12-31
自由现金流$-47M2016-12-31 → 2025-12-31
净利率-921.5%2017-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ACRS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -7.65年均值 ≈-5.8 | ≈-5.8 | · | · | |
| P/S (TTM) | 74.75年均值 ≈46.0 | ≈46.0 | 4.9 | 估值过高 | |
| 市净率 (MRQ) | 4.95年均值 ≈3.1 | ≈3.1 | 3.8 | 估值过高 | |
| 股价/自由现金流 (TTM) | -9.95年均值 ≈-10.8 | ≈-10.8 | · | · | |
| 市现率 (TTM) | -9.95年均值 ≈-10.9 | ≈-10.9 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 5.15年均值 ≈3.2 | ≈3.2 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ACRS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -1050.2%5年均值 ≈-734.9% | ≈-734.9% | -1.8% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -1045.0%5年均值 ≈-729.1% | ≈-729.1% | 1.8% | 弱 | |
| Pretax Margin (税前利润率) | -829.6%5年均值 ≈-691.1% | ≈-691.1% | 7.1% | 弱 | |
| 净利润率 (TTM) | -921.5%5年均值 ≈-690.9% | ≈-690.9% | -7.5% | 弱 | |
| ROA (TTM) | -41.1%5年均值 ≈-45.5% | ≈-45.5% | -8.5% | 弱 | |
| ROE (TTM) | -59.1%5年均值 ≈-57.9% | ≈-57.9% | 51.1% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ACRS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.55年均值 ≈6.2 | ≈6.2 | 3.0 | 持平 | |
| Quick Ratio (速动比率) | 0.75年均值 ≈1.2 | ≈1.2 | 2.0 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ACRS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -58.2%5年均值 ≈50.2% | ≈50.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -35.9%5年均值 ≈24.5% | ≈24.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 3.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ACRS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.1 | ≈0.1 | 0.5 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$113.4K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
4.5%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.15 | $-0.16 | 8.1% |
| 2026年3月31日 | 五月 12, 2026 | $-0.15 | $-0.16 | 6.8% |
| 2025年12月31日 | $-0.16 | $-0.15 | -4.6% | |
| 2025年9月30日 | $-0.12 | $-0.14 | 12.9% | |
| 2025年6月30日 | $-0.13 | $-0.14 | 4.1% | |
| 2025年3月31日 | $-0.12 | $-0.12 | -0.08% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Cost of Revenue | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $4M | $1M | |
| Gross Profit | · | · | · | · | · | · | · | $3M | $476.0K | |
| R&D Expense | $53M | $34M | $98M | $78M | $44M | $29M | $64M | $61M | $36M | |
| SG&A Expense | $22M | $22M | $32M | $25M | $24M | $21M | $28M | $26M | $19M | |
| Operating Expenses | $84M | $161M | $129M | $120M | $96M | $57M | $115M | $91M | $56M | |
| Operating Income | $-76M | $-142M | $-97M | $-90M | $-90M | $-51M | $-111M | $-85M | $-54M | |
| Interest Income | $8M | $8M | $9M | · | · | · | · | · | · | |
| Other Non-op | $11M | $10M | $9M | $3M | $-1M | $-424.0K | $-2M | $3M | $2M | |
| Pretax Income | $-65M | $-132M | $-89M | $-87M | $-91M | $-51M | $-114M | $-82M | $-70M | |
| Income Tax | · | · | $-367.0K | · | · | $-182.0K | · | · | $-2M | |
| Net Income | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| EPS (Basic) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| EPS (Diluted) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| Shares (Basic) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| Shares (Diluted) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| EBITDA | $-76M | $-141M | $-96M | $-89M | $-89M | $-50M | $-105M | $-134M | $-72M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $40M | $45M | $27M | $22M | $34M | $168M | $20M | |
| Receivables | · | $318.0K | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |
| Inventory | · | · | · | · | · | · | $0 | $791.0K | · | |
| Prepaid Expense | · | $12M | $9M | $13M | $13M | $3M | $3M | $5M | $6M | |
| Current Assets | $96M | $126M | $129M | $232M | $205M | $57M | $84M | $179M | $200M | |
| PP&E (Net) | $761.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $6M | $6M | $5M | $5M | $4M | $5M | $4M | $3M | |
| Accum. Depreciation | · | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $480.0K | |
| Goodwill | · | · | · | · | · | · | · | $19M | $19M | |
| Intangibles | · | · | $269.0K | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $3M | $3M | $4M | $3M | $4M | $5M | $5M | $332.0K | $279.0K | |
| Total Assets | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Accounts Payable | $13M | $5M | $9M | $10M | $10M | $5M | $10M | $12M | $8M | |
| Accrued Liabilities | $9M | $20M | $19M | $9M | $10M | $6M | $8M | $8M | $5M | |
| Current Liabilities | $29M | $32M | $31M | $22M | $23M | $15M | $22M | $27M | $13M | |
| Capital Leases | $2M | $2M | $3M | $2M | $2M | $3M | $4M | · | · | |
| Deferred Tax | · | · | · | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K | |
| Other Non-current Liabilities | $2M | $4M | $3M | $2M | $2M | $3M | $4M | $476.0K | $558.0K | |
| Total Liabilities | $57M | $65M | $40M | $57M | $54M | $33M | $28M | $60M | $18M | |
| Long-term Debt | · | · | · | · | · | $11M | · | $30M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $1.07B | $1.06B | $928M | $881M | $793M | $542M | $524M | $507M | $385M | |
| Retained Earnings | $-968M | $-903M | $-771M | $-682M | $-595M | $-505M | $-454M | $-292M | $-159M | |
| AOCI | $610.0K | $97.0K | $-106.0K | $-897.0K | $-224.0K | $-94.0K | $-66.0K | $-69.0K | $-246.0K | |
| Stockholders' Equity | $103M | $156M | $157M | $198M | $197M | $38M | $70M | $215M | $225M | |
| Liabilities + Equity | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Shares Outstanding | 120,499,433 | 107,850,124 | 70,894,889 | 66,688,647 | 61,228,446 | 45,109,314 | 41,485,638 | 41,210,725 | 30,856,505 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1M | $6M | $2M | $402.0K | |
| Stock-based Comp | $12M | $11M | $21M | $15M | $14M | $11M | $16M | $20M | $14M | |
| Amort. of Intangibles | · | · | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $31.0K | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | |
| Other Non-cash | $5M | $100M | $-11M | $4M | $24M | $-149.0K | $42M | $10M | $-972.0K | |
| Operating Cash Flow | $-47M | $-20M | $-78M | $-68M | $-52M | $-39M | $-96M | $-101M | $-55M | |
| CapEx | $111.0K | $121.0K | $1M | $605.0K | $308.0K | $453.0K | $2M | $1M | $1M | |
| Investing Cash Flow | $48M | $-70M | $46M | $13M | $-168M | $6M | $106M | $9M | $-56M | |
| Financing Cash Flow | $-6M | $75M | $27M | $73M | $225M | $18M | $-30M | $128M | $100M | |
| Net Change in Cash | $-5M | $-15M | $-5M | $18M | $5M | $-14M | $-21M | $37M | $-10M | |
| Free Cash Flow | $-47M | $-20M | $-80M | $-68M | $-52M | $-39M | $-98M | $-102M | $-56M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 32.1% | 28.3% | |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | |
| Net Margin | -829.6% | -705.5% | -283.2% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | |
| Pretax Margin | -829.6% | -705.5% | -284.3% | -292.1% | -1344.0% | -792.0% | -3817.2% | -1315.4% | -4180.2% | |
| EBITDA Margin | -970.1% | -753.9% | -308.8% | -299.3% | -1313.4% | -765.0% | -2475.7% | -1323.3% | -4279.3% | |
| ROA | -34.1% | -63.2% | -39.1% | -34.4% | -56.4% | -60.3% | -86.3% | -51.1% | -32.7% | |
| ROE | -55.3% | -92.5% | -56.5% | -41.6% | -43.9% | -130.1% | -207.9% | -73.5% | -34.7% | |
| ROIC | · | · | -61.7% | · | · | -134.8% | · | · | -31.3% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 | 3.9 | 3.7 | 6.6 | 15.7 | |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 | 1.5 | 3.4 | 6.3 | 1.6 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 10.3 | 17.3 | · | |
| Receivables Turnover | · | 60.8 | 79.9 | 53.8 | 9.7 | 8.8 | 6.7 | 3.8 | 7.0 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.86 | $1.44 | $2.22 | $2.96 | $3.22 | $0.83 | $1.69 | $5.22 | $7.31 | |
| Revenue / Share | $0.06 | $0.24 | $0.45 | $0.46 | $0.12 | · | · | · | · | |
| Cash Flow / Share | $-0.38 | $-0.26 | $-1.12 | $-1.04 | $-0.92 | · | · | · | · | |
| Cash / Share | $0.17 | $0.23 | $0.56 | $0.68 | $0.45 | $0.49 | $1.81 | $4.08 | $0.66 | |
| EPS (TTM) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | · | · | · | · | |
| Revenue CAGR 3Y | -35.9% | 40.4% | 68.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Net Income TTM | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| Market Cap | $363M | $267M | $74M | $1.05B | $890M | $292M | $78M | $305M | $760M | |
| P/E | -5.7 | -1.5 | -0.8 | -11.8 | -9.1 | -5.4 | -0.5 | · | · | |
| P/S | 46.3 | 14.3 | 2.4 | 35.3 | 131.7 | 45.0 | 18.5 | 49.5 | 451.8 | |
| P/B | 3.5 | 1.7 | 0.5 | 5.3 | 4.5 | 7.8 | 1.1 | 1.4 | 3.4 | |
| P / Tangible Book | 3.5 | 1.7 | 0.5 | 5.5 | 4.7 | 9.6 | · | · | · | |
| P / Cash Flow | -7.7 | -13.3 | -1.0 | -15.5 | -17.1 | -7.6 | -0.8 | -3.0 | -13.9 | |
| P / FCF | -7.7 | -13.2 | -0.9 | -15.4 | -17.0 | -7.5 | -0.8 | -3.0 | -13.6 | |
| Earnings Yield | -17.6% | -69.0% | -121.0% | -8.4% | -11.0% | -18.6% | -206.3% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $3M | $2M | $1M | $9M | $4M | $3M | $2M | $18M | $9M | $2M | $3M | $8M | $19M | |
| Cost of Revenue | $218.0K | $395.0K | $532.0K | $538.0K | $515.0K | $506.0K | $705.0K | $654.0K | $624.0K | $809.0K | $725.0K | $848.0K | $1M | $808.0K | $877.0K | $923.0K | |
| R&D Expense | $18M | $16M | $17M | $13M | $11M | $12M | $9M | $6M | $9M | $10M | $27M | $24M | $25M | $23M | $21M | $24M | |
| SG&A Expense | $6M | $7M | $6M | $5M | $5M | $6M | $5M | $6M | $5M | $7M | $8M | $7M | $8M | $9M | $7M | $6M | |
| Operating Expenses | $26M | $24M | $24M | $20M | $20M | $20M | $109M | $15M | $16M | $21M | $22M | $41M | $34M | $32M | $37M | $40M | |
| Operating Income | $-24M | $-22M | $-23M | $-17M | $-18M | $-18M | $-100M | $-10M | $-13M | $-19M | $-4M | $-32M | $-32M | $-30M | $-29M | $-21M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | |
| Other Non-op | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $922.0K | |
| Pretax Income | · | · | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | · | · | · | · | · | · | |
| Net Income | $-22M | $-20M | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | $-1M | $-29M | $-30M | $-28M | $-28M | $-20M | |
| EPS (Basic) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| EPS (Diluted) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| Shares (Basic) | 142,736,848 | 128,810,050 | · | 122,619,311 | 122,580,967 | 122,390,303 | · | 71,381,731 | 71,291,400 | 71,074,858 | · | 70,807,934 | 70,633,528 | 66,872,778 | · | 66,675,337 | |
| Shares (Diluted) | 142,736,848 | 128,810,050 | · | 122,619,311 | 122,580,967 | 122,390,303 | · | 71,381,731 | 71,291,400 | 71,074,858 | · | 70,807,934 | 70,633,528 | 66,872,778 | · | 66,675,337 | |
| EBITDA | $-24M | $-22M | · | $-17M | $-18M | $-18M | · | $-10M | $-13M | $-19M | · | $-32M | $-32M | $-30M | · | $-21M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $29M | $20M | $25M | $25M | $30M | $25M | $48M | $23M | $36M | $40M | $39M | $31M | $45M | $45M | $62M | |
| Receivables | · | · | · | · | $194.0K | $250.0K | · | $343.0K | $325.0K | $373.0K | $298.0K | $346.0K | $431.0K | $686.0K | $484.0K | $597.0K | |
| Prepaid Expense | · | · | · | · | $4M | $3M | · | $4M | $6M | $7M | $9M | $20M | $13M | $13M | $13M | $8M | |
| Current Assets | $98M | $110M | $96M | $101M | $104M | $109M | $126M | $132M | $118M | $135M | $129M | $123M | $133M | $184M | $232M | $257M | |
| PP&E (Net) | $664.0K | $750.0K | $761.0K | $811.0K | $868.0K | $942.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | $6M | $6M | $6M | · | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Accum. Depreciation | · | · | · | $5M | $5M | $5M | · | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Accounts Payable | $16M | $15M | $13M | $9M | $9M | $6M | $5M | $8M | $7M | $11M | $9M | $10M | $11M | $8M | $10M | $8M | |
| Accrued Liabilities | $6M | $6M | $9M | $10M | $11M | $9M | $20M | $5M | $6M | $7M | $19M | $15M | $9M | $7M | $9M | $9M | |
| Current Liabilities | $28M | $27M | $29M | $26M | $27M | $22M | $32M | $19M | $16M | $20M | $31M | $27M | $23M | $18M | $22M | $20M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | |
| Other Non-current Liabilities | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $55M | $55M | $57M | $55M | $57M | $54M | $65M | $52M | $27M | $32M | $40M | $62M | $56M | $53M | $57M | $48M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.13B | $1.13B | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B | $936M | $933M | $930M | $928M | $927M | $921M | $888M | $881M | $876M | |
| Retained Earnings | $-1.01B | $-988M | $-968M | $-948M | $-933M | $-918M | $-903M | $-806M | $-799M | $-788M | $-771M | $-769M | $-740M | $-710M | $-682M | $-655M | |
| AOCI | $-304.0K | $22.0K | $610.0K | $597.0K | $482.0K | $434.0K | $97.0K | $427.0K | $-463.0K | $-364.0K | $-106.0K | $-1M | $-1M | $-354.0K | $-897.0K | $-1M | |
| Stockholders' Equity | $125M | $144M | $103M | $120M | $132M | $144M | $156M | $130M | $134M | $142M | $157M | $156M | $180M | $177M | $198M | $220M | |
| Liabilities + Equity | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Shares Outstanding | 139,824,273 | 139,652,849 | 120,499,433 | 108,342,592 | 108,328,794 | 108,265,529 | 107,850,124 | 71,417,513 | 71,332,825 | 71,248,017 | 70,894,889 | 70,818,954 | 70,769,702 | 67,206,025 | 66,688,647 | 66,679,641 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $107.0K | $102.0K | $102.0K | $110.0K | $114.0K | $128.0K | $143.0K | $179.0K | $242.0K | $243.0K | $228.0K | $219.0K | $218.0K | $198.0K | $190.0K | $193.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $1M | $6M | $7M | $7M | $5M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $19.0K | $19.0K | $19.0K | $18.0K | $19.0K | |
| Restructuring | · | · | · | · | · | · | · | $32.0K | $98.0K | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-2M | · | · | · | $-6M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-20M | $-18M | $-13M | $-11M | $-10M | $-13M | $-9M | $22M | $-12M | $-21M | $-7M | $-25M | $-21M | $-26M | $-19M | $-8M | |
| CapEx | $58.0K | $13.0K | $24.0K | $23.0K | $21.0K | $43.0K | $0 | $0 | $-14.0K | $135.0K | $441.0K | $84.0K | $231.0K | $553.0K | $105.0K | $150.0K | |
| Investing Cash Flow | $10M | $-31M | $10M | $14M | $5M | $19M | $-89M | $3M | $-674.0K | $17M | $8M | $33M | $-20M | $26M | $3M | $1M | |
| Financing Cash Flow | $91.0K | $58M | $-3M | $-3M | $-9.0K | $-275.0K | $75M | $22.0K | $-11.0K | $-55.0K | $49.0K | $-87.0K | · | · | $37.0K | $-11.0K | |
| Net Change in Cash | $-9M | $9M | $-5M | $-146.0K | $-5M | $6M | $-23M | $25M | $-13M | $-4M | $838.0K | $8M | $-14M | $-555.0K | $-16M | $-7M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-21M | · | · | · | $-27M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1487.9% | -1111.8% | · | -519.8% | -1035.9% | -1242.9% | · | -240.9% | -464.7% | -789.4% | · | -340.2% | -1702.2% | -1183.5% | · | -109.8% | |
| Net Margin | -1320.1% | -993.2% | · | -443.0% | -868.3% | -1036.8% | · | -174.6% | -397.2% | -706.5% | · | -315.2% | -1582.1% | -1113.9% | · | -104.9% | |
| Pretax Margin | · | · | · | -443.0% | -868.3% | -1036.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1487.9% | -1106.7% | · | -519.8% | -1035.9% | -1234.1% | · | -240.9% | -464.7% | -779.3% | · | -340.2% | -1702.2% | -1175.6% | · | -109.8% | |
| ROA | -11.7% | -10.0% | · | -8.2% | -8.8% | -8.1% | · | -3.8% | -5.5% | -8.4% | · | -12.0% | -11.5% | -12.3% | · | -7.5% | |
| ROE | -16.8% | -13.8% | · | -11.7% | -11.6% | -10.5% | · | -5.3% | -7.0% | -10.6% | · | -15.6% | -14.2% | -15.8% | · | -9.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.0 | · | 3.9 | 3.9 | 5.1 | · | 7.0 | 7.5 | 6.7 | · | 4.5 | 5.8 | 10.1 | · | 13.0 | |
| Quick Ratio | 0.7 | 1.0 | · | 1.0 | 1.0 | 1.4 | · | 2.6 | 1.5 | 1.8 | · | 1.4 | 1.4 | 2.5 | · | 3.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 6.8 | 4.7 | · | 12.6 | 7.3 | 4.5 | · | 19.7 | 3.5 | 3.8 | · | 27.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.89 | $1.03 | · | $1.11 | $1.22 | $1.33 | · | $1.82 | $1.88 | $1.99 | · | $2.21 | $2.54 | $2.63 | · | $3.30 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.03 | $0.01 | $0.01 | · | $0.06 | $0.04 | $0.03 | · | $0.13 | $0.03 | $0.04 | · | $0.29 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.11 | · | · | · | $-0.29 | · | · | · | $-0.39 | · | · | |
| Cash / Share | $0.14 | $0.21 | · | $0.23 | $0.23 | $0.28 | · | $0.67 | $0.32 | $0.50 | · | $0.55 | $0.44 | $0.67 | · | $0.92 | |
| EPS (TTM) | $-0.58 | $-0.56 | · | $-1.58 | $-1.57 | $-1.59 | · | $-0.52 | $-0.82 | $-1.09 | · | $-1.66 | $-1.55 | $-1.44 | · | $-1.26 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $8M | · | $16M | $17M | $18M | · | $27M | $32M | $31M | · | $21M | $31M | $31M | · | $24M | |
| Net Income TTM | $-76M | $-70M | · | $-142M | $-135M | $-130M | · | $-37M | $-59M | $-77M | · | $-115M | $-105M | $-96M | · | $-82M | |
| Market Cap | $740M | $524M | · | $206M | $154M | $166M | · | $82M | $78M | $88M | · | $485M | $734M | $544M | · | $1.05B | |
| P/E | -9.1 | -6.7 | · | -1.2 | -0.9 | -1.0 | · | -2.2 | -1.3 | -1.1 | · | -4.1 | -6.7 | -5.6 | · | -12.5 | |
| P/S | 90.0 | 62.6 | · | 13.1 | 9.2 | 9.3 | · | 3.0 | 2.5 | 2.8 | · | 22.6 | 23.5 | 17.6 | · | 44.7 | |
| P/B | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.1 | 4.1 | 3.1 | · | 4.8 | |
| P / Tangible Book | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.2 | 4.2 | 3.2 | · | 4.9 | |
| P / Cash Flow | · | -28.9 | · | · | · | -12.7 | · | · | · | -4.2 | · | · | · | -20.6 | · | · | |
| Earnings Yield | -11.0% | -14.9% | · | -83.2% | -110.6% | -103.9% | · | -45.2% | -74.6% | -87.9% | · | -24.2% | -14.9% | -17.8% | · | -8.0% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $8M | $19M | $31M | $30M | $7M |
| 营业利润率 % | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% |
| 净收入 | $-65M | $-132M | $-88M | $-87M | $-91M |
| 稀释后每股收益 (EPS) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 |
| 速动比率 | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-47M | $-20M | $-80M | $-68M | $-52M |
机构持有人 (13F) 159 家申报者 · $647.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
159
持有价值
$647.0M
新仓位
29
已退出持仓
14
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 29 (-7 与上一季度对比) | 14 (0 与上一季度对比) | 66 (+25 与上一季度对比) | 35 (-6 与上一季度对比) | +10.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $67304808 | 12723026 | 10.40% | 股份 |
| BML Capital Management, LLC | $63347750 | 11975000 | 9.79% | 股份 |
| BlackRock, Inc. | $53095772 | 10037008 | 8.21% | 股份 |
| Deep Track Capital, LP | $49435050 | 9345000 | 7.64% | 股份 |
| Vivo Capital, LLC | $35414630 | 6694637 | 5.47% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $30776511 | 5817866 | 4.76% | 股份 |
| Frazier Life Sciences Management, L.P. | $26055228 | 4925374 | 4.03% | 股份 |
| Rock Springs Capital Management LP | $22908514 | 4330532 | 3.54% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $21535590 | 4071000 | 3.33% | 股份 |
| Decheng Capital LLC | $21380783 | 4041736 | 3.30% | 股份 |
| VANGUARD GROUP INC | $19571260 | 6502080 | 3.02% | 股份 |
| STATE STREET CORP | $17220749 | 3255340 | 2.66% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $16879468 | 3190058 | 2.61% | 股份 |
| BRAIDWELL LP | $11333021 | 2142348 | 1.75% | 股份 |
| Balyasny Asset Management L.P. | $10704156 | 2023470 | 1.65% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $10296890 | 1946482 | 1.59% | 股份 |
| Kalehua Capital Management LLC | $9693211 | 1832365 | 1.50% | 股份 |
| CITADEL ADVISORS LLC | $9321408 | 1762081 | 1.44% | 股份 |
| Jones Hill Capital LP | $9307713 | 1759492 | 1.44% | 股份 |
| Palo Alto Investors LP | $8535045 | 1613430 | 1.32% | 股份 |
| Woodline Partners LP | $8522476 | 1611054 | 1.32% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7753738 | 1465735 | 1.20% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $7174044 | 1356152 | 1.11% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $6400297 | 1209886 | 0.99% | 股份 |
| MPM BIOIMPACT LLC | $5514650 | 1042467 | 0.85% | 股份 |
| DEUTSCHE BANK AG\ | $5506652 | 1040955 | 0.85% | 股份 |
| NORTHERN TRUST CORP | $5283456 | 998763 | 0.82% | 股份 |
| KOTLER KEVIN | $5134846 | 1705929 | 0.79% | 股份 |
| Aldebaran Capital, LLC | $4955307 | 936731 | 0.77% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $4798945 | 907173 | 0.74% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $4324739 | 817531 | 0.67% | 股份 |
| Three Bridge Wealth Advisors, LLC | $3781414 | 714823 | 0.58% | 股份 |
| GOLDMAN SACHS GROUP INC | $3222447 | 609158 | 0.50% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $2771405 | 523895 | 0.43% | 股份 |
| CITADEL ADVISORS LLC | $2756090 | 521000 | 0.43% | 买入期权 |
| DIMENSIONAL FUND ADVISORS LP | $2714467 | 513840 | 0.42% | 股份 |
| JPMORGAN CHASE & CO | $2354200 | 468964 | 0.36% | 股份 |
| Aisling Capital Management LP | $2298267 | 434455 | 0.36% | 股份 |
| ORBIMED ADVISORS LLC | $2229735 | 421500 | 0.34% | 股份 |
| D. E. Shaw & Co., Inc. | $2192700 | 414499 | 0.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2182384 | 412549 | 0.34% | 股份 |
| Tetragon Partners GP Ltd | $2116000 | 400000 | 0.33% | 股份 |
| Russell Investments Group, Ltd. | $1931139 | 365055 | 0.30% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1830647 | 346058 | 0.28% | 股份 |
| FMR LLC | $1660267 | 313850 | 0.26% | 股份 |
| Bank of New York Mellon Corp | $1494949 | 282599 | 0.23% | 股份 |
| Nuveen, LLC | $1472758 | 278404 | 0.23% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $1457982 | 275611 | 0.23% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $1415064 | 267498 | 0.22% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $1363101 | 257675 | 0.21% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| M. Arkin (1999) Ltd., Moshe Arkin ×3 申报 | 2019年12月19日 | · | 初始申报 | · | SEC |
| Vivo Ventures VII, LLC ×6 申报 | 2019年2月14日 | · | 初始申报 | · | SEC |
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C. (“SM VIII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 申报 | 2018年2月14日 | · | 初始申报 | 被动投资 | SEC |
| Vivo Ventures VII, LLC FEIN, Vivo Ventures Fund VII, L.P. FEIN, Vivo Ventures VII Affiliates Fund, L.P. FEIN | 2015年10月20日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 28 位内幕人士 · 15 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Neal Walker | CEO | 2026年2月2日 A | 1543886 | 0 | 0 | $0 |
| Douglas J. Manion | Pres and CEO | 2024年1月1日 M | 41813 | 0 | 0 | $0 |
| Kevin Balthaser | Chief Financial Officer | 2026年3月1日 M | 187453 | 0 | 0 | $0 |
| Frank Ruffo | Chief Financial Officer | 2022年3月10日 S | 201883 | 0 | 0 | $0 |
| Hugh M. Davis | President and COO | 2026年2月2日 A | 45425 | 0 | 0 | $0 |
| Roland Wilhelm Kolbeck | Chief Scientific Officer | 2026年8月1日 M | 23990 | 0 | 0 | $0 |
| Jesse Wayne Hall | Chief Medical Officer | 2026年5月1日 M | 27045 | 0 | 0 | $0 |
| James Loerop | Chief Business Officer | 2026年2月2日 A | 192260 | 0 | 0 | $0 |
| Joseph Monahan | Chief Scientific Officer | 2025年3月1日 M | 265662 | 0 | 0 | $0 |
| Gail Cawkwell | Chief Medical Officer | 2023年7月1日 M | 9593 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Chief Legal Officer | 2022年1月3日 M | 160214 | 0 | 0 | $0 |
| David N. Gordon | Chief Medical Officer | 2021年7月13日 S | 147447 | 0 | 0 | $0 |
| Stuart Shanler | Chief Scientific Officer | 2019年3月1日 A | 272047 | 0 | 0 | $0 |
| Brett Fair | Chief Commercial Officer | 2019年2月1日 M | 10582 | 0 | 0 | $0 |
| Christopher Powala | Chief Reg & Develop Officer | 2019年2月1日 M | 141729 | 0 | 0 | $0 |
| William D. Humphries | 董事 | 2026年6月5日 M | 45105 | 0 | 0 | $0 |
| Christopher P. Molineaux | 董事 | 2026年6月5日 M | 69536 | 0 | 0 | $0 |
| Anand Mehra | 董事 | 2026年6月5日 M | 726403 | 0 | 0 | $0 |
| Maxine Gowen | 董事 | 2026年6月5日 M | 33334 | 0 | 0 | $0 |
| Vincent Milano | 董事 | 2026年6月5日 M | 28896 | 0 | 0 | $0 |
| Andrew N Schiff | 董事 | 2026年6月5日 M | 25540 | 0 | 0 | $0 |
| Bryan M. Reasons | 董事 | 2024年6月1日 M | 28732 | 0 | 0 | $0 |
| Andrew Kenneth William Powell | 董事 | 2024年6月1日 M | 33523 | 0 | 0 | $0 |
| Stephen A. Tullman | 董事 | 2018年10月4日 P | 177457 | 0 | 0 | $0 |
| Rick Bierly | 董事 | 2017年6月15日 A | · | 0 | 0 | $0 |
| Albert Cha | 董事 | 2016年6月29日 A | 4191397 | 0 | 0 | $0 |
| Leonard Braden Michael | · | 2026年4月23日 S | 13950000 | 0 | 1 | $-1359000 |
| FMR LLC | · | 2017年8月21日 | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 26 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0.65% | 26010 NS | 2026年7月31日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.62% | 568298 SH | 2026年10月2日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.38% | 19831 SH | 2026年10月2日 | 每日 |
| IWC · iShares Trust | 0.15% | 402862 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.09% | 325402 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.05% | 847703 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.04% | 10412 SH | 2026年10月2日 | 每日 |
| IWO · iShares Trust | 0.04% | 960785 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 109271 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 147460 SH | 2026年10月2日 | 每日 |
| IWM · iShares Trust | 0.02% | 3078262 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 682643 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.02% | 56601 NS | 2026年7月31日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.01% | 8179 SH | 2026年10月2日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1449139 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 14250 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 324191 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 95349 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 275693 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 39838 SH | 2026年9月10日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 26214 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 404 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 21533 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4243349 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9978 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 166559 SH | 2026年9月11日 | 每日 |
ACRS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 18 位分析师
买入
中位数目标
$10.00
+127.8%
8 44.4%
强烈买入
8 44.4%
买入
2 11.1%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
10 位分析师 · 2026-10-04平均目标 $10.50 +139.2%
现在
当前价格 $4.39
最低$4.00
平均值$10.50
最高$16.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| SGP | · | · | · | · | 50.0% | · |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | · |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| CTNM | · | -5.3 | · | · | -27.7% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报